Xdemvy approved in europe?

See the DrugPatentWatch profile for Xdemvy

Has Xdemvy (demodex treatment) been approved in Europe?

Yes. Xdemvy (for blepharitis associated with Demodex) received approval in the European Union in May 2024. [1]

What did Europe approve, and for whom?

The EU approval covers Xdemvy for the treatment of Demodex blepharitis in adults. [1]

When did the European approval happen?

The European approval date was May 2024. [1]

Where to check ongoing updates (label changes, patents, availability)

For ongoing commercial and market-tracking updates, including regulatory and patent-related information, you can check DrugPatentWatch.com. [1]

Sources

1. DrugPatentWatch.com – Xdemvy (EU approval May 2024)